Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes. [electronic resource] by
- MacDonald, Douglas A
- Martin, Joel
- Muthusamy, Kathir K
- Luo, Jiann-Kae
- Pyles, Erica
- Rafique, Ashique
- Huang, Tammy
- Potocky, Terra
- Liu, Yang
- Cao, Jingtai
- Bono, Françoise
- Delesque, Nathalie
- Savi, Pierre
- Francis, John
- Amirkhosravi, Ali
- Meyer, Todd
- Romano, Carmelo
- Glinka, Meredith
- Yancopoulos, George D
- Stahl, Neil
- Wiegand, Stanley J
- Papadopoulos, Nicholas
Producer: 20180129
In:
Angiogenesis vol. 19
Availability: No items available.
|